Florian Grebien
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Mutant TP53 allelic states in human hematopoietic stem and progenitor cells.
Journal: Leukemia
Published: February 16, 2026
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.
Journal: HemaSphere
Published: October 27, 2025
A long-range enhancer at -52Kb drives expression of the COUP-TFII transcription factor in erythroid cells.
Journal: Scientific reports
Published: October 24, 2025
Harnessing the E3 ligase SPOP for targeted degradation of the NUP98::KDM5A fusion oncoprotein.
Journal: Cell reports
Published: June 17, 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AML.
Journal: Blood advances
Published: December 27, 2024
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.
Journal: Leukemia
Published: October 15, 2024
Off-Target Inhibition of Human Dihydroorotate Dehydrogenase (hDHODH) Highlights Challenges in the Development of Fat Mass and Obesity-Associated Protein (FTO) Inhibitors.
Journal: ACS pharmacology & translational science
Published: September 04, 2024
Probing condensate microenvironments with a micropeptide killswitch.
Journal: Nature
Published: June 21, 2024
The adsorption of drugs on nanoplastics has severe biological impact.
Journal: Scientific reports
Published: June 20, 2024
Differential regulation of mitochondrial uncoupling protein 2 in cancer cells.
Journal: Biochimica et biophysica acta. Bioenergetics
Published: May 15, 2024
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12.
Journal: Nature communications
Published: March 06, 2024
Last Updated: 09/26/2026